Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Avivagen Inc
Bullboard Posts
User Avatar Image
(82)
•••
Comment by fatboy92on Nov 18, 2013 10:26am
152 Views
Post# 21915567

RE:RE:Total of 3.4 million, nice!

RE:RE:Total of 3.4 million, nice!"Avivagen believes that a strong balance sheet will assist in securing global development, marketing and distribution arrangements for our products: Potential business partners need to know that Avivagen can follow-through on its commitments." stated C.E.O. & President Cameron Groome. "Combining the amount raised in our first closing in October with this second closing, Avivagen has raised a total of 3.42 million dollars - more than double our minimum targeted amount. We now look forward to realizing our major corporate objectives." concluded Mr. Groome Nice to know VIV will have enough cash to continue with the business plan and shouldnt have to raise more capital in the future. 3.4 million isnt always easily raised and having some deep pocketed believers will only help in the future....FB
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities